18 Results for "

PB1

" in MedChemExpress (MCE) Product Catalog:
Products (18)

18 Results for "PB1" in MCE Product Catalog:

1
1 Cited Publications
Referencia número: HY-145446
No. CAS: 1997319-84-2
Pureza:  99.84%
Target:  

SWI/SNF Complex

Áreas de investigación:  

Metabolic Disease

SGC-SMARCA-BRDVIII, a chemical probe, is a potent and selective inhibitor of SMARCA2/4 and PB1(5), with Kds of 35 nM, 36 nM, and 13 nM, respectively. SGC-SMARCA-BRDVIII also inhibits PB1(2) and PB1(3), with Kds of 3.7 and 2.0 μM, respectively. SGC-SMARCA-BRDVIII can block adipogenesis of 3T3-L1 murine fibroblasts [1] .
loading...
    loading...
Referencia número: HY-W017189
No. CAS: 4593-90-2
3-Phenylbutyric acid is metabolized by initial oxidation of the benzene ring and by initial oxidation of the side chain. 3-Phenylbutyric acid can be used to isolate Rhodococcus rhodochrous PB1 from compost soil [1] .
loading...
    loading...
Referencia número: HY-138648
No. CAS: 188714-28-5
Pureza:  98.99%
Target:  

ERK

Áreas de investigación:  

Neurological Disease

PB1 is a potent intracellular disulfide reducing agent with several advantages including good cell permeability, the ability to form a high intracellular concentration gradient, and stability. PB1 is a borane-protected TCEP (tris(2-carboxyethyl)phosphine) analogue. PB1 increases retinal ganglion cells survival after axotomy in vitro at nanomolar and picomolar concentrations. PB1 can be used for the research of neuroprotective [1] .
loading...
    loading...
Referencia número: HY-162793
Áreas de investigación:  

Infection

RdRP-IN-8 (compound 45) is an anti-influenza virus compound. RdRP-IN-8 inhibits viral RNA-dependent RNA polymerase (RdRP) activity by disrupting heterodimerization of PA and PB1 subunits (EC50=0.13 μM) [1].
loading...
    loading...
Referencia número: HY-122645
No. CAS: 1915012-19-9
Target:  

SWI/SNF Complex

Áreas de investigación:  

Cancer

SMARCA2-IN-4 (Compound 26) is an inhibitor for SWI/SNF chromatin remodeling complexe SMARCA by targeting the bromodomains. SMARCA2-IN-4 exhibits high affinity for PB1(5), SMARCA2B and SMARCA4 with Kd of 124, 262 and 417 nM [1].
loading...
    loading...
Referencia número: HY-100858
No. CAS: 433238-84-7
Target:  

Influenza Virus

Áreas de investigación:  

Infection

PP7 is a potent PB1-PB2 interaction inhibitor with an IC50 of 8.6 μM, and their inhibition against viral polymerase activity (IC50=9.5 μM). PP7 shows antiviral activities against influenza A virus (IAV), including A(H1N1)pdm09 (EC50=1.4 μM), A(H7N9) and A(H9N2) subtypes [1].
loading...
    loading...
Referencia número: HY-122573
No. CAS: 1914047-59-8
Áreas de investigación:  

Cancer

Bromodomain inhibitor-13 (Compound 1) is an analog of PFI-3 (HY-12409). Bromodomain inhibitor-13 is a bromodomain-containing protein (BCP) inhibitor. Bromodomain inhibitor-13 targets SMARCA2, SMARCA4, PB1(5), and second bromodomain of PB1 (PB1(2)) with KD values of 37, 53, 30, and 190 nM, respectively [1].
loading...
    loading...
Referencia número: HY-144668
No. CAS: 3035088-22-0
Áreas de investigación:  

Infection

RdRP-IN-4 (compound 11q), an aryl benzoyl hydrazide analog, is an orally active influenza A virus RNA-dependent RNA polymerase (RdRp) inhibitor by interacting with the PB1 subunit. RdRP-IN-4 exhibits potent inhibitory activity against the avian H5N1 flu strain with an EC50 of 18 nM in MDCK cells. RdRP-IN-4 displays excellent potency against the the H1N1 (A/PR/8/34) Flu A strain and Flu B strain (B/Lee/1940) with EC50 values of 53 nM and 20 nM, respectively. RdRP-IN-4 significantly inhibits the expression level of viral nucleoprotein (NP) in a dose-dependent manner. RdRP-IN-4 exhibits significant antiviral activity in infected mice [1].
loading...
    loading...
Referencia número: HY-W017189R
No. CAS: 4593-90-2
3-Phenylbutyric acid is metabolized by initial oxidation of the benzene ring and by initial oxidation of the side chain. 3-Phenylbutyric acid can be used to isolate Rhodococcus rhodochrous PB1 from compost soil [1] .
loading...
    loading...
Referencia número: HY-176822
No. CAS: 2650530-02-0
Áreas de investigación:  

Others

SGC-BRDVIII-NC (Compound 35) is a negative control compound of SMARCA2/4 and PB1 bromodomain (BRD) inhibitor. SGC-BRDVIII-NC completely abolishes protein-ligand binding capacity with the methylation of the phenolic hydroxyl moiety. SGC-BRDVIII-NC can be used for adipogenesis research [1].
loading...
    loading...
Referencia número: HY-184089
No. CAS: 2921556-65-0
Target:  

p62 Mitophagy

Áreas de investigación:  

Cardiovascular Disease Neurological Disease

ATB1071 is a brain-penetrant and orally active p62/SQSTM1 activator. ATB1071 binds to the p62-ZZ domain, promotes PB1-dependent p62 self-polymerization, and activates p62-mediated mitophagy. ATB1071 can be used for the research of Leigh syndrome, cerebral ischemia-reperfusion injury[1].
loading...
    loading...
Referencia número: HY-P81431
Synonyms: BAF180; hPB1; PB1; PBrm1; polybromo 1; Polybromo-1D

Host:  

Rabbit

Application:  

IHC-P

Reactivity:  

Human

loading...
    loading...
Referencia número: HY-P81431A
Synonyms: BAF180; hPB1; PB1; PBrm1; polybromo 1; Polybromo-1D

Host:  

Rabbit

Application:  

IHC-P

Reactivity:  

Human

loading...
    loading...
Referencia número: HY-133908
No. CAS: 1914047-60-1
Áreas de investigación:  

Others

PFI-3 Control is an inactive analog of PFI-3 (HY-12409), serving as an inactive negative control. PFI-3 Control shows no detectable binding activity toward purified PB1 (5), SMARCA2A, SMARCA2B, and SMARCA4 family VIII bromodomain proteins [1].
loading...
    loading...
Referencia número: HY-RS10105
Áreas de investigación:  

Others

PBRM1 Human Pre-designed siRNA Set A contains three designed siRNAs for PBRM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Referencia número: HY-P82421
Synonyms: CPC9; CYP2C; CYP2C10; CYP2C9; CYPIIC9; P450 PB1; P450MP

Host:  

Rabbit

Application:  

WB, ICC/IF, FC

Reactivity:  

Human

loading...
    loading...
Referencia número: HY-180269
Áreas de investigación:  

Infection

Anti-Influenza agent 10 (Compound 41) is an influenza A virus RNA-dependent RNA polymerase (RdRp) inhibitor. Anti-Influenza agent 10 exhibits potent antiviral activity against A/PR/8/34(H1N1) with an IC50 of 0.29μM and a KD of 4.11 μM. Anti-Influenza agent 10 can inhibit the assembly of the viral RdRp complex by disrupting the protein interaction between PA and PB1 subunits, thereby blocking the transcription and replication of the viral genome. Anti-Influenza agent 10 shows significant broad-spectrum effects on multiple influenza virus strains, such as H3N2, H3N8 and H9N2 with IC50 values of 3.96, 1.91 and 1.45 μM. Anti-Influenza agent 10 can be used for the research of influenza A Virus Infection [1].
loading...
    loading...
Referencia número: HY-RS17918
Áreas de investigación:  

Others

Pbrm1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pbrm1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
  • 1